19089662

Source:http://linkedlifedata.com/resource/pubmed/id/19089662

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0038952, umls-concept:C0205179, umls-concept:C0206698, umls-concept:C0281361, umls-concept:C1519810
pubmed:issue	2-4
pubmed:dateCreated	2008-12-17
pubmed:abstractText	The CA 19-9 tumour marker is increasingly used to monitor response to therapy in patients with pancreatic adenocarcinoma. Serum CA 19-9 levels have also been shown to correlate with survival. However, their role in cholangiocarcinoma is less clear.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101479627
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/CA-19-9 Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:issn	1941-6628
pubmed:author	pubmed-author:AdamsonDouglas J ADJ, pubmed-author:AliClinton WCW, pubmed-author:HighleyMartin SMS, pubmed-author:KayeThomas FTF, pubmed-author:PolignanoFrancesco MFM, pubmed-author:TaitIain SIS
pubmed:issnType	Print
pubmed:volume	38
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	108-14
pubmed:meshHeading	pubmed-meshheading:19089662-Adenocarcinoma, pubmed-meshheading:19089662-Aged, pubmed-meshheading:19089662-Aged, 80 and over, pubmed-meshheading:19089662-Antimetabolites, Antineoplastic, pubmed-meshheading:19089662-Bile Duct Neoplasms, pubmed-meshheading:19089662-Bile Ducts, Intrahepatic, pubmed-meshheading:19089662-CA-19-9 Antigen, pubmed-meshheading:19089662-Cholangiocarcinoma, pubmed-meshheading:19089662-Deoxycytidine, pubmed-meshheading:19089662-Female, pubmed-meshheading:19089662-Humans, pubmed-meshheading:19089662-Male, pubmed-meshheading:19089662-Middle Aged, pubmed-meshheading:19089662-Neoplasm Staging, pubmed-meshheading:19089662-Pancreatic Neoplasms, pubmed-meshheading:19089662-Prognosis, pubmed-meshheading:19089662-Retrospective Studies, pubmed-meshheading:19089662-Survival Rate, pubmed-meshheading:19089662-Treatment Outcome, pubmed-meshheading:19089662-Tumor Markers, Biological
pubmed:year	2007
pubmed:articleTitle	CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma.
pubmed:affiliation	Department of Cancer Medicine, Ninewells Hospital, Dundee, DD1 9SY, UK. clintonali@nhs.net
pubmed:publicationType	Journal Article